Digital therapeutics trailblazer Pear Therapeutics filed for Chapter 11 bankruptcy on Friday following months of setbacks.
Why it matters: The Boston-based company made history as the first to secure regulatory clearance for a prescription digital therapeutic — but ran into issues securing insurance reimbursement.
